Evidence map›Paper›PMID 29114388›Full record

ArticleClinical & translational immunology2017

Epistatic interactions between mutations of TACI (

Rohan Ameratunga, Wikke Koopmans, See-Tarn Woon, Euphemia Leung, Klaus Lehnert, Charlotte A Slade, Jessica C Tempany, Anselm Enders, Richard Steele, Peter Browett and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Re-evaluation of the contribution ofJournal of human immunity · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Immunogenetic Landscape in Pediatric Common Variable Immunodeficiency.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19.The journal of allergy and clinical immunology. In practice · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Rohan AmeratungaDepartment of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand.
Wikke KoopmansDepartment of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand.
See-Tarn WoonDepartment of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand.
Euphemia LeungCancer Society Research Centre, University of Auckland, Auckland, New Zealand.
Klaus LehnertSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.
Charlotte A SladeDepartment of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Jessica C TempanyDepartment of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Anselm EndersDepartment of Immunology and Infectious Disease, John Curtin School of Medical Research and Centre for Personalised Immunology, Australian National University, Canberra, ACT, Australia.ORCID 0000-0001-5933-6463
Richard SteeleDepartment of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand.
Peter BrowettDepartment of Hematology, LabPlus, Auckland City Hospital, Auckland, New Zealand.
Philip D HodgkinDepartment of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Vanessa L BryantDepartment of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Auckland City Hospital · NZUniversity of Auckland · NZThe Royal Melbourne Hospital · AUThe University of Melbourne · AUAustralian National University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency disorders (CVID) are a group of primary immunodeficiencies where monogenetic causes account for only a fraction of cases. On this evidence, CVID is potentially polygenic and epistatic although there are, as yet, no examples to support this hypothesis. We have identified a non-consanguineous family, who carry the C104R (c.310T>C) mutation of the Transmembrane Activator Calcium-modulator and cyclophilin ligand Interactor (TACI,

Identifiers

PMID29114388
PMCPMC5671988
OpenAlexW2766419049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.